Given that increases in cell-surface JAM-C levels are associated with a number of disease states, including atherosclerosis and rheumatoid arthritis [19,24], and the K283R mutant exhibits a slower turnover, we focused on the potential role of ubiquitylation in JAM-C trafficking and degradation. The gene discussed is JAM3; the disease is atherosclerosis.